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ABSTRACT
Aim To assess the relative effects of different types of 
exercise and other non-pharmaceutical interventions on 
cancer-related fatigue (CRF) in patients during and after 
cancer treatment.
Design Systematic review and indirect-comparisons 
meta-analysis.
Data sources Articles were searched in PubMed, 
Cochrane CENTRAL and published meta-analyses.
Eligibility criteria for selecting 
studies Randomised studies published up to January 
2017 evaluating different types of exercise or other 
non-pharmaceutical interventions to reduce CRF in any 
cancer type during or after treatment.
Study appraisal and synthesis Risk of bias 
assessment with PEDro criteria and random effects 
Bayesian network meta-analysis.
Results We included 245 studies. Comparing the 
treatments with usual care during cancer treatment, 
relaxation exercise was the highest ranked intervention 
with a standardisedmean difference (SMD) of −0.77 
(95% Credible Interval (CrI) −1.22 to −0.31), while 
massage (−0.78; −1.55 to −0.01), cognitive–
behavioural therapy combined with physical activity 
(combined CBT, −0.72; −1.34 to −0.09), combined 
aerobic and resistance training (−0.67; −1.01 to −0.34), 
resistance training (−0.53; −1.02 to −0.03), aerobic 
(−0.53; −0.80 to −0.26) and yoga (−0.51; −1.01 to 
0.00) all had moderate-to-large SMDs. After cancer 
treatment, yoga showed the highest effect (−0.68; 
−0.93 to −0.43). Combined aerobic and resistance 
training (−0.50; −0.66 to −0.34), combined CBT (−0.45; 
−0.70 to −0.21), Tai-Chi (−0.45; −0.84 to −0.06), CBT 
(−0.42; −0.58 to −0.25), resistance training (−0.35; 
−0.62 to −0.08) and aerobic (−0.33; −0.51 to −0.16) 
showed all small-to-moderate SMDs.
Conclusions Patients can choose among different 
effective types of exercise and non-pharmaceutical 
interventions to reduce CRF.
InTRoDuCTIon
The National Comprehensive Cancer Network 
(NCCN)1 defines cancer-related fatigue (CRF) as ‘a 
distressing, persistent, subjective sense of physical, 
emotional and/or cognitive tiredness or exhaus-
tion related to cancer or cancer treatment that is 
not proportional to recent activity and interferes 
with usual functioning'. CRF is one of the most 
common and distressing symptoms of cancer and 
cancer treatment2 that can be prevalent before 
treatment onset and usually increases during 
therapy.3 4 Compared with the fatigue experienced 
by healthy individuals, CRF is more severe, more 
distressing and less likely to be relieved by rest.1 
Overall, the prevalence of CRF has been estimated 
between 25% and 99%, depending on the patient 
population, type of treatment received and method 
of assessment.5 CRF can persist for up to 5 years 
after completion of treatment or even longer6–8 and 
is associated with significant impairment in overall 
quality of life during and after treatment.9 Besides, 
in a large longitudinal study of patients with breast 
cancer, CRF predicted decreased recurrence-free 
survival and overall survival.2
Although the aetiology of CRF is still unknown, 
some possible biological mechanisms have been 
postulated, such as proinflammatory cytokines, 
hypothalamus–pituitary–adrenal axis deregula-
tion,10 circadian rhythm desynchronisation, skeletal 
muscle wasting and genetic deregulation.1 11 Bower5 
described the following risk factors for CRF: genetic 
risk factors (eg, single nucleotide polymorphisms), 
psychological (eg, depression) and behavioural 
risk factors (eg, physical inactivity). Some of these 
factors might be targeted by exercise. For example, 
skeletal muscle wasting may be avoided or reversed 
by resistance exercise.
A broad variety of non-pharmacological inter-
ventions are used against CRF and many trials, 
systematic reviews and meta-analyses have been 
published.12–44 The Oncology Nursing Society 
‘Putting Evidence into Practice’ tool on CRF 
proposed exercise and physical activity as a first-
line intervention for CRF.45 Furthermore, this 
guideline states that apart from erythropoiesis-stim-
ulating agents (Erythropoietin) and low-dose dexa-
methasone for patients with advanced cancer (both 
drugs with potential serious adverse events), there 
is to date not enough scientific evidence to support 
the effectiveness of pharmacological agents and 
nutritional supplements to reduce CRF in patients 
with cancer. Similar recommendations have been 
made by the NCCN guidelines for CRF.1 Taken 
together, for most cancer types there is evidence to 
support exercise or other non-pharmaceutical treat-
ments as effective options to reduce CRF during 
and after treatment. However, it is still unclear 
which of these anti-CRF interventions yields the 
largest treatment effect, as there is no systematic 
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review comparing the effects of different non-pharmaceutical 
interventions on CRF. An indirect-comparisons meta-analysis, 
using direct evidence (interventions compared within one trial) 
and indirect evidence (comparing interventions across different 
trials), could inform clinicians and scientists on the ranking of 
the effectiveness of those interventions. Indirect-comparisons 
meta-analysis is an upcoming statistical method already used in 
other medical fields.46
The aim of the present indirect-comparisons (network) 
meta-analysis was to assess the relative effects of different types 
of exercise and other non-pharmaceutical interventions on CRF 
in patients with cancer during and after cancer treatment. In 
this paper, we focused on exercise-related non-pharmacological 
interventions, such as physical activity, aerobic and resistance 
training, and relaxation, while nutritional interventions were 
excluded.
METhoDS
This study is reported based on the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses.47 An a priori written 
protocol exists but was not registered.
Design
We conducted a systematic review and an indirect-comparisons 
(network) meta-analysis.
Database and search strategy
The digital databases PubMed, Cochrane Database of Systematic 
Reviews and Cochrane Controlled Clinical Trials (CENTRAL) 
were searched, from inception to 4 January 2017. We developed 
a search strategy for each database (see online supplementary 
appendix 1), without language restriction. The Cochrane highly 
sensitive filter for clinical trials was used.48 In addition, JT and 
RH retrieved reviews and meta-analyses on exercise for CRF and 
screened references of selected articles for additional topic-re-
lated publications.
Inclusion criteria for study selection
Published randomised or quasi-randomised trials evaluating the 
effect of all kind of exercise or other non-pharmaceutical inter-
ventions such as cognitive–behavioural or relaxation interven-
tions on CRF or vitality in patients with CRF during or after 
active cancer treatments were eligible for inclusion. All cancer 
types were included, because we assumed that CRF is a general 
cancer problem and that the working mechanisms and effects of 
the different interventions targeting CRF would be similar across 
all cancer diagnoses.
Exclusion criteria
We excluded trials comparing drugs or nutritional supplemen-
tations, acupuncture, electroacupuncture, acupressure, moxi-
bustion or healing without touching the patients (eg, Reiki or 
healing over the phone), as well as expressive writing interven-
tion because we focused on exercise and conventional physio-
therapy-related interventions (eg, movement therapy, relaxation 
or massage). Studies with an intervention duration of <3 weeks 
as well as interventions aiming to improve sleep quality were 
also excluded.
Classification in ‘during’ or ‘after’ cancer treatment
Studies including patients receiving chemotherapy or radio-
therapy as the initial cancer treatment or as treatment in the 
presence of metastasis or cancer recurrence were classified as 
‘during’, while those studies including patients currently not on 
chemotherapy or radiotherapy were defined as ‘after’. Studies 
including both types of patients were classified according to 
the majority of patients. Studies including patients receiving 
androgen suppression therapy without chemotherapy or radio-
therapy were defined as ‘after’.
Study selection
Two reviewers (RH, JT) independently screened titles and 
abstracts for eligibility. In case of disagreement, consensus was 
reached through discussion. At this stage, studies were excluded 
only if the available information in the title or the abstract made it 
clear that the article was not eligible. Full texts were retrieved for 
the other articles and read independently by these two reviewers. 
A consensus meeting was held to discuss disagreements.
Assessment of risk of bias
Risk of bias (RoB) was assessed using the ratings published in the 
PEDro database. We used items of random sequence generation, 
allocation concealment, baseline differences between groups, 
blinding of participants, blinding of therapists and blinding of 
assessors, incomplete outcome data and intention-to-treat anal-
ysis. If the study was not scored in the PEDro database, one 
reviewer (RH or JT) assessed RoB using the same PEDro rating 
scale criteria. RoB was provided only with the intention to give 
a detailed overview of the characteristics of the included studies 
(ie, RoB was not used to exclude studies). Furthermore, we 
assessed the risk for publication bias with the comparisons of the 
active interventions against the control groups with funnel plots 
and Egger’s tests,49 which regresses the effect estimates on their 
standard errors, weighted by the inverse of the variance.
Data extraction
Study characteristics were extracted into a spreadsheet by one of 
three reviewers (RH, JT, LNB). Data for the calculation of effect 
sizes for fatigue or vitality from the first time point after the end 
of the period of the intervention under assessment in the specific 
study were extracted by one reviewer (RH) and controlled by a 
second reviewer (JT). Change values were extracted whenever 
mean and SD of the changes were available or when the available 
data allowed their calculation. If change values were not available 
or could not be calculated, post-treatment values for mean and 
SD were extracted. If SD were missing, different methods were 
used to estimate the SD, such as using p values, CIs or extracting 
data from figures. If only median and IQRs were presented, 
means were estimated by the median while SDs were calculated 
by dividing the IQR by 1.35.48 The effect sizes were converted 
by reversing signs for means so that higher values always indi-
cated more fatigue.50 The corresponding authors were contacted 
in case of missing data or unclear reporting. If in a given study 
fatigue was assessed by more than one questionnaire, we selected 
the questionnaire presented as primary outcome or as the first 
result for fatigue.
Summary measures
Because fatigue was assessed with different questionnaires, we 
used standardised mean difference (SMD) as the effect size 
measure. The SMD is an effect size without metric and is calcu-
lated as the difference in mean outcome between two groups, 
divided by the pooled SD of the measure. For the interpretation 
of the SMD, following benchmarking anchors were used: 0.2 
indicates a small effect size, 0.5 a moderate effect size and 0.8 a 
large effect size.51
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Data synthesis
Bayesian network meta-analysis (random effects models) was 
used to compare the relative effectiveness of the different inter-
ventions under investigation. Bayesian Inference Using Gibbs 
Sampling (BUGS) was performed with Just Another Gibbs 
Sampler (JAGS). JAGS is designed to work with the R language 
and environment for statistical computation.52 From within R, 
we used the gemtc53 and the rjags package.54
To rank the interventions, the probability of each interven-
tion being the most effective, the second most effective, etc was 
calculated. Rankograms were established and the surface under 
the cumulative ranking curve (SUCRA55) was calculated for 
each intervention. The surface under the cumulative ranking 
curve represents an inversely scaled average rank of the inter-
vention, scaled such that it is 1 if the intervention always ranks 
first and 0 if the intervention always ranks last. The SUCRA 
of a specific intervention can be interpreted as the average 
proportion of interventions worse than the intervention under 
consideration.
The differences of the SMD between the direct and indirect 
comparisons were selected to evaluate the fundamental assump-
tion of consistency, that is, that direct and indirect evidence are 
compatible or that all studies are exchangeable. Heterogeneity 
was assessed using Higgins I2 for each pairwise comparison.
Non-informative uniform distribution of effect sizes and preci-
sion were chosen for all parameters of the model to enable the 
data to dominate the prior information in the final results. Four 
Markov chains were run simultaneously with different initial 
values, which were set arbitrarily. The convergence to a stable 
solution was checked visually with the Brooks-Gelman-Rubin 
method. The first 50 000 samples were discarded and the poste-
rior summaries were based on 500 000 simulations. The poste-
rior distributions of the SMDs are presented with the medians 
and 95% Crls (95% CrI), representing a range of values in which 
the SMD lies with a probability of 95%.
Results of all analyses (during and after cancer treatment 
and sensitivity analyses for effects of small-study samples) 
are presented in forest plots comparing all interventions with 
control as well as in matrices showing effect estimates of all 
comparisons.
Comparison of consistency and inconsistency models
The deviance information criteria (DIC) of the consistency model 
and the unrelated means model (inconsistency) were compared, 
and the model with the lower DIC value was selected.
To further explore the inconsistency between the direct and 
indirect evidence, we ran an ensemble of node-splitting models.56
Sensitivity analyses
Because small studies tend to have larger effects compared with 
larger studies, we conducted a sensitivity analysis excluding 
studies with less than 25 patients per intervention arm.57
RESulTS
Study selection and characteristics
The systematic search in the databases and the hand search 
yielded 1471 articles, and we screened 573 full texts and finally 
included 245 for further qualitative and quantitative analyses 
(see figure 1). Characteristics of the included studies are shown 
in the online supplementary appendix 1 and supplementary 
appendix 2. The date of publication ranged from 1989 to 2017. 
Of the included articles, 112 articles reported on patients during 
cancer treatment and 133 articles after the treatment. Five 
studies included patients both during and after treatment and 
were classified according to the higher proportion of patients 
(three studies classified during, and two after). The duration of 
the interventions ranged from 3 to 52 weeks and the follow-up 
from 0 to 12 weeks after the end of the intervention. Most of the 
studies reported on women with breast cancer (n=126; 51%), 
followed by studies reporting on mixed patient groups (n=52; 
21%; 79% of these were breast cancer), prostate cancer (18; 
7%), haematopoietic stem cell transplantation (10; 4%) and 
colorectal cancer (7, 3%).
Figure 1 Flow chart of the study selection process. 
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RoB of included trials
Over all comparisons, the random sequence generation was 
adequate in most trials (97%); allocation concealment was 
problematic in 61% of the trials. Baseline characteristics were 
not balanced in 17% of the studies; patients and outcome 
assessor could not be blinded in most trials (99%), therapists 
were never blinded. More than 15% of drop-outs were present 
in 36% of the trials and only 51% of the trials reported an 
intention-to-treat analysis. Supplementary appendix 2 shows 
the assessment of the RoB in the included trials separate for 
each direct comparison, separated for during and after cancer 
treatment.
There is some evidence for small-study effects, as assessed 
with the Egger’s test in the pairwise meta-analysis for the 
comparisons aerobic versus control, combined resistance 
and aerobic training versus control, combined cognitive –
behavioural therapy (CBT) versus control and relaxation versus 
control. One reason for the presence of these small-study 
effects might be publication bias.
Indirect-comparisons meta-analysis for exercise and non-
pharmaceutical interventions during cancer treatment
The network consisted of 103 studies with two arms and 9 
studies with three arms reporting on 13 different interven-
tions (34 arms on aerobic, 23 combined aerobic and resistance 
training, 18 psychosocial and CBT (CBT psychosocial), 12 relax-
ation (including stretching, meditation, etc), 10 yoga, 10 resis-
tance training, 6 multimodal trainings (exercise and psychosocial 
combined, combined CBT), four massage, three healing-touch, 
two dance and one music therapy; 93 arms were control groups). 
The number of direct comparisons and patients per comparison 
are shown in figure 2.
Comparing the deviance criteria for the consistency and 
inconsistency models (unrelated means model) revealed that 
Figure 2 Plots of the two networks (during and after cancer treatment). The size of the circles corresponds to the number of patients within the 
groups, the width of the lines between the treatment circles indicates the statistical precision of the comparison (ie, inverse of the variance). The 
numbers on or besides the lines between the treatments indicate the number of trials comparing the two treatments and the numbers in parentheses 
indicate the number of patients in the given comparison. Red coloured lines indicate that more than 50% of the trials had no allocation concealment 
or more than 15% drop-outs; green dashed lines indicate that 50% or more of the trials had correct allocation concealment and less than 15% drop-
outs. CBT, cognitive–behavioural therapy .
Figure 3 Forest plots for the comparisons between the active interventions and the control intervention (usual care) for the studies performed 
during cancer treatment. The left side of the panel shows all studies. The right side shows only the studies with more than 25 patients per arm (on 
average). CBT, cognitive–behavioural therapy; SMD, standardised mean difference; SUCRA, surface under the cumulative ranking curve; 95% Crl, 
95% Crl.
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the consistency model was to be preferred (DICconsistency=452.7, 
DICinconsistency=457.413).
The effect sizes for the differences between all interventions 
are presented in the online supplementary appendix 5 and 
supplementary appendix 6. Figure 3 presents the findings of the 
indirect-comparisons meta-analysis as effect sizes and their 95% 
CrI for the different types of exercise and non-pharmaceutical 
interventions on CRF during cancer treatment compared with 
usual care (control group).
Relaxation was the best ranked intervention with an SMD of 
−0.77 (95% CrI −1.22 to −0.31) for the reduction of fatigue. 
Moderate-to-large effect sizes were observed for massage (SMD 
−0.78 (−1.55 to −0.01), CBT combined with physical activity 
(combined CBT, SMD −0.72 with 95% CrI −1.34 to −0.09), 
combined aerobic and resistance training (SMD −0.67 (−1.01 
to −0.34), resistance training (SMD −0.53 with 95% CrI −1.02 
to −0.03), aerobic (SMD −0.53 (−0.80 to −0.26) and yoga 
(SMD −0.51 (−1.01 to 0.00), compared with usual care. The 
other interventions had credible intervals including a zero effect. 
The observed statistical heterogeneity (I2) ranged from 38% to 
96% in the pairwise comparisons (figure 3).
The SUCRA indicated that relaxation was the best ranked 
intervention with a SUCRA of 0.77. The control intervention 
(usual care, ie, no exercise) had the lowest SUCRA (0.12).
In the node-splitting model, no comparison with statistical 
significant inconsistency was observed, and the overall hetero-
geneity was not reduced (88%), indicating that inconsistency did 
not explain the heterogeneity. However, power to detect incon-
sistency is low given the high heterogeneity.
Sensitivity analysis by excluding small studies with less than 
25 patients per arm on average
In the sensitivity analyses to test the effect of smaller sample size 
on the overall weighted mean in the ‘during’ studies, the effect 
sizes were smaller for most of the comparisons; for example, 
the effect size for the combined CBT interventions was reduced 
from −0.72 to −0.28 when excluding smaller studies, with cred-
ible intervals now including the zero effect.
The effect size of massage, combined aerobic and resistance 
training increased.
The exclusion of small studies did not yield in a reduction of 
the heterogeneity.
Indirect-comparisons meta-analysis for exercise and non-
pharmaceutical interventions after cancer treatment
The network consisted of 12 interventions. The majority of 
trials included a non-exercise group (eg, waiting list, usual care). 
The most applied intervention was combined aerobic and resis-
tance training (n=32), followed by aerobic training (n=30) and 
psychosocial /CBT (n=29).
Comparing the deviance criteria for the consistency and 
inconsistency models (unrelated means model) revealed that 
the consistency model was to be preferred (DICconsistency=506.3, 
DICinconsistency=509.3).
The effect sizes for the differences between all interventions are 
presented in the online supplementary appendix 7 (all studies) 
and supplementary appendix 8 (excluding studies with less than 
25 patients per arm on average). The left part of figure 4 pres-
ents the findings of the indirect-comparisons meta-analysis as 
effect sizes and their 95% CrI for the different intervention after 
cancer treatment compared with usual care.
Yoga showed a moderate-to-large effect size (SMD=−0.68, 
95% CrI −0.93 to −0.43) compared with usual care. Combined 
aerobic and resistance training showed a moderate effect size 
with an SMD of −0.50 (95% CrI −0.66 to −0.34). Inspiratory 
muscle training (IMT) and dance therapy also showed moderate 
effect sizes (IMT: −0.57; dance: −0.53) compared with usual 
care, but with a credible interval including a zero effect size 
(IMT: −1.27 to 0.13; dance: −1.17 to 0.11)). Small-to-mod-
erate effect sizes were found for combined CBT (SMD −0.45, 
95% CrI −0.70 to −0.21), Tai-Chi (SMD −0.45, 95% CrI 
−0.84 to −0.06), CBT (SMD −0.42, 95% CrI −0.58 to −0.25), 
resistance (SMD=−0.35, 95% CrI −0.62 to −0.08) and aerobic 
training (SMD=−0.33, 95% Crl −0.51 to −0.16). The other 
interventions had credible intervals including a zero effect size. 
The observed statistical heterogeneity (I2) ranged from 12% to 
84% in the pairwise comparisons (figure 3).
The SUCRA indicated that yoga was the highest ranked inter-
vention with a SUCRA of 0.87. The control intervention (ie, no 
exercise) had the lowest SUCRA (0.08).
The node-splitting model showed no statistical significant 
inconsistency between direct and indirect comparisons.
In the sensitivity analyses to test the effect of smaller sample 
size on the overall weighted mean in the ‘after treatment’ studies, 
the effect size of dance therapy decreased from −0.53 to −0.28, 
Figure 4 Forest plots for the comparisons between the active interventions and the control intervention (usual care) for the studies performed after 
cancer treatment. The left side of the panel shows all studies. The right side shows only the studies with more than 25 patients per arm (on average). 
CBT, cognitive–behavioural therapy; SMD, standardised mean difference; SUCRA, surface under the cumulative ranking curve; 95%Crl, 95% Crl.
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but in both analyses the corresponding 95% CrI included the 
zero effect size. Inspiratory muscle training studies disappeared 
in the sensitivity analysis. The exclusion of small studies did not 
yield in a reduction of the heterogeneity.
DISCuSSIon
This indirect-comparisons meta-analysis, including 245 studies 
evaluating the effects of exercise and other non-pharmaceutical 
interventions on CRF, found strong evidence that several inter-
ventions reduce CRF substantially more than usual care, as was 
shown by the moderate-to-high effect sizes, either during or 
after cancer treatment.
The ranking of the effectiveness of the different types 
of interventions, which was possible due to the Bayesian 
approach, may help healthcare professionals (eg, oncologists, 
nurses, physiotherapists, family practitioners) and patients 
with cancer in their shared clinical decision making process. 
For example, the preferences of the patient, contraindications, 
the availability and the costs of the interventions may influ-
ence their decision. Our ranked interventions help patients 
and practitioners prioritise evidence-based interventions 
during and after treatment. Healthcare professionals may offer 
their patients a variety of exercises or other non-pharmaceu-
tical interventions, such as relaxation, yoga, CBT combined 
with physical activity or resistance or aerobic training, to 
tackle CRF. Since different interventions showed moderate-
to-high effects, patients should choose among these a modality 
that is most convenient for him or her. For example, if a 
patient with cancer does not want to lift weights to protect 
against CRF, he or she might choose to walk, cycle or do yoga 
instead.
Another important finding of this study was that relaxation 
seems to be an effective intervention during cancer-related 
treatment but becomes less important after cancer treatment. 
This indicates that a strategy to tackle CRF efficiently during 
cancer treatment should include relaxation sessions besides the 
personalised exercise or other non-pharmaceutical interven-
tions. After cancer treatment, however, time invested in relax-
ation sessions is less effective and more time should be spent 
with physical activity enhancing interventions. Yoga, on the 
other hand, was beneficial both during and after cancer treat-
ment. The same applies for aerobic, resistance and combined 
aerobic–resistance training, be it on a somewhat lower effect 
size level.
Study strengths and limitations
The strengths of this indirect-comparisons meta-analysis were 
the inclusion of a comprehensive set of types of interventions, 
the large number of included studies, the statistical method and 
the stringent methodological approach.
A major limitation of this study was the difficulty to classify 
the interventions described in the included studies. First, there 
were different kinds of intervention combinations. For example, 
relaxation exercises were often embedded in CBT.58 Second, 
because specific information on training intensity or the extent 
of exercises was lacking in most of the studies, it was not possible 
to analyse the effect of high versus low training intensity or high 
versus low exercise volume. Third, we are well aware that the 
control groups in our network meta-analysis are very heteroge-
neous and that this may strongly increase the heterogeneity of 
the results.
The fact that only two digital databases were searched 
may be another limitation of this review. However, we are 
confident that we did not miss important trials, as we included 
all relevant studies also presented in other previously published 
meta-analyses.
Only the effect sizes at the first time point after the end 
of the interventions were extracted and not those at the later 
follow-up time points. This can also be criticised; however, 
we believe that exercise interventions, just as drugs (eg, for 
high blood pressure), are the most effective during their appli-
cation period only. Therefore, the effect sizes at the end of 
the exercise or other non-pharmaceutical intervention period 
were considered as the most relevant. If a study presented 
more than one questionnaire for the outcome fatigue, data of 
only one were extracted. Methods for the inclusion of more 
than one fatigue questionnaire have been described elsewhere 
(multivariate meta-analysis). However, these methods are still 
in development and require the estimation of the correlations 
between the results yielded by the different fatigue question-
naires, which are most often not reported.
A further limitation might be that the descriptive data were 
only extracted by one reviewer and that the RoB was extracted 
from the PEDro database. Also, that RoB of those studies not 
evaluated in the PEDro database was assessed by only one 
reviewer.
Because of the moderate-to-high RoB, the large number of 
studies with small sample sizes, the risk for publication bias, 
the small number of studies for some pairwise comparisons, the 
moderate-to-high clinical and statistical heterogeneity and the 
low statistical precision, the effect sizes and the ranking of the 
interventions should not be considered as conclusive. Further-
more, the lack of detailed descriptions of the exercise modali-
ties hampered a planned metaregression on the effect of training 
intensity or the extent of exercises on the observed effect sizes.
In this study, all cancer diagnoses were analysed together. This 
may have resulted in an increased heterogeneity and might have 
led to confounding. However, it seems plausible to assume that 
the effects of the modalities targeting CRF are similar across 
diagnoses and other reviews also decided to mix different cancer 
diagnoses.59
For some of the included interventions, only few and very 
small trials were found. Some of them showed no effect (eg, 
Tai-Chi ‘during’ studies) but with large credible intervals which 
were still compatible with a moderate to large beneficial effect 
on fatigue. In the ‘after’ studies, Tai-Chi showed a moderate 
effect size on CRF. Perhaps Tai-Chi is a too strenuous exercise 
modality for patients during active cancer treatment. If this is 
the reason for the non-effect during cancer treatment, it might 
be possible to adapt the intensity of the Tai-chi classes. This is 
supported by the fact that yoga showed a large effect during and 
after cancer treatment. To clarify these questions, larger studies 
are needed for Tai-chi interventions.
Comparison with other studies
There are several meta-analyses evaluating the effect of exer-
cise and other non-pharmaceutical interventions on CRF12–44 
and most of them are in favour of exercise or non-pharma-
ceutical interventions as compared with usual care (control). 
The conclusions of this study are based on similar sets of 
published studies as used in the other meta-analyses. This 
indirect-comparisons meta-analysis allowed for additional 
conclusions, such as the ranking of the different exercise and 
non-pharmaceutical interventions. The NCCN guidelines on 
CRF60 and the ‘Putting Evidence into practice guidelines’ 
of the US Oncology Nursing Society45 differentiate between 
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active (during) treatment and post-treatment (after) phase 
and recommend for both phases exercise activities, such as 
walking, stretching and cycling to manage CRF. NCCN guide-
lines also recommend endurance and resistance training. The 
results of this review are in line with previous reports but in 
addition, they suggest that during cancer treatment relaxation 
exercises may be the first choice to manage CRF and that yoga 
and combined CBT also might have a large effect size on CRF. 
For the management of CRF after cancer treatment, the results 
suggest that yoga might be most effective but that combined 
aerobic and resistance training, CBT, combined CBT and 
Tai-Chi all showed moderate effect sizes.
Different working mechanisms may explain the effective-
ness of the interventions included in this study. Active exer-
cises (eg, resistance training, aerobic training, dance, yoga, 
etc) may counteract the decreased level of activity during or 
after cancer treatment, and hence improve physical capacity. 
Furthermore, higher physical activity levels may have a bene-
ficial effect on mental health.61 Psychosocial interventions 
aim at reducing fatigue through an improved coping with 
the stressful situation and activity management.42 Relaxation 
techniques, massage, music therapy or yoga may also help to 
reduce stress or anxiety levels and decrease fatigue via the 
adrenal–pituitary axis.33 62
Implications for practice
These findings may have important clinical implications. 
They suggest that the effectiveness of the different types of 
non-pharmaceutical interventions varies depending on the 
cancer treatment status of the patients. During cancer treat-
ment, relaxation training seems to have the largest effect. In 
addition, health professionals should consider physical activity 
such as yoga, combinations of exercise and psychosocial inter-
ventions, resistance training or endurance training as beneficial 
interventions.
After the cancer treatment, relaxation seems no longer the 
best choice for reducing CRF. Hence, in this stage the health 
professionals should propose more physical activity enhancing 
interventions to their clients.
Unfortunately, the results of this study do not allow for a 
more detailed specification of the exercise modalities such as 
training intensity or exercise volume. Health professionals 
might consult the ranking of the interventions presented in this 
study, when planning an optimal, individually adapted exer-
cise programme to reduce CRF. Because some of the interven-
tions included in this analysis showed quite similar effects and 
SUCRA values (see ranking in figures 3 and 4), health profes-
sionals now have a choice between different interventions and 
can for example take into account the individual patient’s 
preferences.
Surveys reported that 25%–50% of oncologists already 
discuss the possibility of initiating exercise therapy during and 
after cancer treatment with their patients.63–65 We hope that 
the present review may contribute to increase this number. 
Furthermore, our results emphasise that patients can really 
choose from a list of effective exercise or non-pharmaceu-
tical alternatives to reduce CRF. This may increase adher-
ence to the intervention. However, fatigue itself might be 
a barrier to exercise among patients with cancer and survi-
vors.66 Thus, appropriate strategies should be tailored to the 
individual needs and abilities of patients and re-evaluated 
regularly.
Our study supports the importance of offering high-
quality continuous education for physicians and other health 
professionals (such as the American College of Sports Medi-
cine initiative). For example, physiotherapists working with 
patients with cancer should be aware that depending on the 
treatment status, interventions such as relaxation exercises or 
yoga may be even more effective in such patients to prevent 
or reduce CRF as compared with traditional aerobic or 
strength exercise. While the latter interventions are part of a 
physiotherapy educational programme, the first are probably 
not. Hence, continued training programmes on CBT, relax-
ation therapy, yoga, Tai-Chi or dance therapy are needed to 
enhance the health literacy and the intervention options of 
physiotherapists working in the field of oncology, and collab-
orations with practitioners who have those skills should be 
considered. This will allow healthcare professionals to provide 
evidence-based, individualised, safe and effective exercise 
programmes.
Implications for research
We agree with the ‘no one-size-fits-all remedy exists’ statement 
of Tomlinson and colleagues.28 This review provides indications 
on what type of exercise might be better suited to improve CRF 
in patients but it does not allow to suggest clear cut exercise 
modalities. The current knowledge on exercise modalities such 
What is already known?
 ► There is evidence for the effectiveness of different 
non-pharmaceutical interventions for cancer-related fatigue 
(CRF) in patients during and after cancer treatment.
 ► The relative effects and the ranking of the different 
non-pharmaceutical interventions are not known.
What are the new findings?
 ► During cancer treatment, relaxation, massage, cognitive–
behavioural therapy (CBT) combined with physical activity, 
aerobic and resistance training (alone or combined), and yoga 
were able to reduce CRF, showing moderate-to-large effect 
sizes.
 ► After cancer treatment, yoga showed a large effect size for 
the reduction of CRF, while combined aerobic and resistance 
training, CBT alone or combined with physical activity, Tai-Chi 
as well as aerobic or resistance training alone all showed 
moderate effect sizes.
how might it impact on clinical practice in the near 
future?
 ► During cancer treatment, relaxation exercises, massage, 
cognitive-behavioural therapy (CBT) combined with physical 
activity, aerobic and resistance training (alone or combined), 
and yoga might be the first choice to manage CRF.
 ► After cancer treatment, the clinician might encourage more 
physical activity enhancing interventions.
 ► Patient and healthcare professionals can now choose out of a 
variety of evidence-based non-pharmaceutical interventions 
according to patients’ preferences and abilities to tackle CRF.
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as training intensity, exercise volume, resting intervals, training 
frequency, etc is not yet optimal. The influence of exercise on 
the inflammation–immunity axis is very complex. Too much 
exercise may be detrimental for the inflammatory and immune 
reaction process while an optimal exercise dosage may posi-
tively regulate the inflammation–immunity system. There is but 
limited knowledge on the complex interactions between the 
patient, exercise regulation of the inflammation–immune axis 
and tumour biology.67
Future studies might evaluate the different modalities and how 
these modalities should be adapted to the patients’ individual 
situations or preferences. For example, different resistance 
training intensities and volumes should be compared in large 
randomised trials.
Further important research topics are adverse events, 
patient preferences, exercise adherence and economic eval-
uations such as cost-effectiveness and cost–utility studies. 
Finally, methodological research is needed to evaluate which 
questionnaires are best suited to assess CRF and to decide 
on the best tools, which might increase comparability across 
studies.
ConCluSIon
Although exercise and non-pharmaceutical therapies have 
been shown to be effective in reducing CRF, there was a 
lack of comparison between different types of exercises. 
Evidence from this indirect-comparisons meta-analysis indi-
cated that during cancer treatment, relaxation, massage, 
CBT combined with physical activity, aerobic and resistance 
training (alone or combined), as well as yoga, all showed 
similar moderate-to-large effect sizes. After cancer treat-
ment, the importance of relaxation seems to decrease while 
yoga might be the best option. Combined aerobic and resis-
tance training, CBT, combined CBT and Tai-Chi showed all 
moderate effect sizes. This enables the patient and the health-
care professional to choose out of a variety of evidence-based 
alternatives according to patients’ preference and abilities to 
tackle CRF.
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